| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |